Metraipolis › archive › dc_3f7e03cd31be
Macrocytosis as an Early Pharmacodynamic Marker of Imatinib Efficacy in Chronic Myeloid Leukemia — Europe PMC PMID:41598845
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41598845
- DOI
- 10.3390/jcm15020908
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T13:44:53.975Z
- SHA-256 of the archived text
a0cc2f397b04d893a384e0bf12021c2384cd43d8108017a31f1ef4ad09794dc1- Stable URL of this page
https://metraipolis.com/documento/dc_3f7e03cd31be
How to cite
Macrocytosis as an Early Pharmacodynamic Marker of Imatinib Efficacy in Chronic Myeloid Leukemia — Europe PMC PMID:41598845 — Europe PMC (en), https://europepmc.org/article/MED/41598845 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3f7e03cd31be (Metraipolis archive dc_3f7e03cd31be, sha256 a0cc2f397b04d893a384e0bf12021c2384cd43d8108017a31f1ef4ad09794dc1)
BibTeX
@misc{dc3f7e03cd31be,
title = {Macrocytosis as an Early Pharmacodynamic Marker of Imatinib Efficacy in Chronic Myeloid Leukemia — Europe PMC PMID:41598845},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41598845},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3f7e03cd31be; sha256 a0cc2f397b04d893a384e0bf12021c2384cd43d8108017a31f1ef4ad09794dc1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41598845. Agents can read the archived copy with the MCP tool read_document.